Showing 941-950 of 3001 results for "".
The Influence of Family Health History on the Diagnosis of hATTR Amyloidosis
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-influence-of-family-health-history-on-the-diagnosis-of-hattr-amyloidosis/30094/Bernice Bennett, genealogist, health education specialist, and co-founder and faculty member of the Midwest African American Genealogy Institute, discusses the Family Health History Road Trip, which emphasizes the important role family health history can play in driving earlier diagnosis of hATTR amBehavioral and Integrative Therapies for Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/behavioral-and-integrative-therapies-for-headache/31518/Many patients who may benefit from these treatments may not be aware nonpharmacologic approaches exist.Cannabinoids and Psychedelics for Headache Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-psychedelics-for-headache-management/32131/Reports of success in self-treatment of primary headache disorders with cannabis and psilocybin have led to clinical trials studying their efficacy and safety.Genetic Testing & Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetic-testing-neuromuscular-disorders/31920/The cost of genetic testing has decreased significantly, and the results are priceless.Practical Recommendations for Monitoring Response to Amyloid-Targeting Treatments for Early Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/practical-recommendations-for-monitoring-response-to-amyloid-targeting-treatments-for-early-alzheimer-disease/36189/The authors present practical recommendations for using cognitive assessments and amyloid PET scanning to monitor response to amyloid-targeting treatments in clinical practice.Hyperglycemia Management
https://practicalneurology.com/diseases-diagnoses/stroke/hyperglycemia-management/31861/The role of hyperglycemia management after ischemic stroke remains elusive.Neural Antibodies as Diagnostic Biomarkers of Autoimmune Encephalitis and Inflammatory Demyelinating Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neural-antibodies-as-diagnostic-biomarkers-of-autoimmune-encephalitis-and-inflammatory-demyelinating-disease/32103/Neural antibodies are diagnostic biomarkers of autoimmune encephalitis, NMOSD, and MOGAD.Management of Poststroke Epilepsy: An Update
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/management-of-poststroke-epilepsy-an-update/32188/Poststroke seizure management is a clinical and research priority to improve prognosis.Dementia Insights: Antiamyloid Antibody Therapy in Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-antiamyloid-antibody-therapy-in-alzheimer-disease/31928/The saga continues for development of antiamyloid monoclonal antibodies, aducanumab, lecanemab, donanemab, and gantenerumab for Alzheimer disease.Spotlight on Sleep: Beyond the Polysomnogram—Modern Approaches to Diagnosing Sleep Apnea
https://practicalneurology.com/diseases-diagnoses/sleep/beyond-the-polysomnogram-modern-approaches-to-diagnosing-sleep-apnea/35814/The evolution from in-laboratory polysomnography to flow-based home sleep apnea testing and, more recently, wearables reflects advancements in sleep technologies and a move toward patient-centered care.